Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Discontinuation of tyrosine kinase inhibitor in children with chronic myeloid leukemia (JPLSG STKI-14 study)

Discontinuation of tyrosine kinase inhibitor in children with chronic myeloid leukemia (JPLSG STKI-14 study)
Shima H et al. Blood, November 2019

Link to full abstract

 

Successful haploidentical stem cell transplant with post-transplant cyclophosphamide for isolated central nervous system blast crisis in a child with chronic myeloid leukemia

Successful haploidentical stem cell transplant with post-transplant cyclophosphamide for isolated central nervous system blast crisis in a child with chronic myeloid leukemia
Chatterjee G et al. J Pediatr Hematol Oncol, November 2019 (epub ahead of print)

Link to full abstract

 

Pediatric chronic myeloid leukemia presenting in a mixed phenotypic blast crisis: A rare occurrence (Bhattacharya J et al. Turk H Haematol, August 2019)

Pediatric chronic myeloid leukemia presenting in a mixed phenotypic blast crisis: A rare occurrence
Bhattarcharya J et al. Turk H Haematol, August 2019

Link to full abstract

 

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia (Hijiya N et al. Blood, September 2019)

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia
Hijiya N et al. Blood, September 2019

Link to full abstract

 

The small problem when treating childhood chronic myeloid leukemia (Suttorp M et al. Pediatr Hematol Oncol, July 2019)

The small problem when treating childhood chronic myeloid leukemia
Suttorp M et al. Pediatr Hematol Oncol, July 2019 (epub ahead of print)

  1. Effect of imatinib on growth in children with chronic myeloid leukemia (Boddu D et al. Pediatr Hematol Oncol, July 2019)
  2. Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia (Liu Y et al. AMB Express, July 2019)
  3. Large amplicon droplet PCR for DNA-based monitoring of pediatric chronic myeloid leukaemia (Krumbholz M et al. J Cell Mol Med, June 2019)
  4. Favourable of de novo advanced phases of childhood chronic myeloid leukemia (Millot F et al. Eur J Cancer, May 2019)